Targeting self-renewal, the process by which stem cells divide and generate progeny ... to be selectively cytotoxic to primary LSCs from AML and other leukemias within 2 h after drug exposure ...
AML originates from a rare population of cells, termed leukemic stem cells (LSCs) or leukemia-initiating cells, which are capable of self-renewal, proliferation and differentiation into malignant ...
Patients with Acute Myeloid Leukemia (AML ... company of Clinical Trials Arena. Cell therapies are used as supportive products after hematopoietic stem cell transplants (HSCT) that aim to either ...
BioLineRx Ltd. (NASDAQ/TASE: BLRX), a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today announced that it has received a Notice of ...
Photovoltaic cell maker Day4 Energy (TSE:DFE) has struck a deal with Taiwan-based solar company Ever Energy to make solar panel cells using the company’s own DNA technology. Vancouver-based Day4 ...